Telephone
61.3.8399.9419
Address
Level 3, Suite 69 574 Plummer Street Port Park-Building 2 Port Melbourne, Victoria (VIC) 3207
Description
Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes in licensing and taking brands to the market in Australia and Asia. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.04 - 0.08
Trade Value (12mth)
AU$1,366.00
1 week
0%
1 month
0%
YTD
-8.62%
1 year
-24.29%
All time high
2.00771
EPS 3 yr Growth
-87.700%
EBITDA Margin
-28.30%
Operating Cashflow
-$6m
Free Cash Flow Return
-119.10%
ROIC
-266.50%
Interest Coverage
-4.70
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
552m
HALO Sector
Staples
Next Company Report Date
30-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Appendix 4C and Quarterly Report for Sep 2023 Quarter
×
Appendix 4C and Quarterly Report for Sep 2023 Quarter |
31 May 23 |
Extension of Voluntary Suspension
×
Extension of Voluntary Suspension |
31 January 22 |
Appendix 4C and Quarterly Report for Dec 2021 Quarter
×
Appendix 4C and Quarterly Report for Dec 2021 Quarter |
30 September 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
30 September 21 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 November 22 |
CEO AGM Letter
×
CEO AGM Letter |
29 November 22 |
AGM Presentation
×
AGM Presentation |
29 November 22 |
Results of Meeting
×
Results of Meeting |
29 June 23 |
Wellnex Life Extends Supply Agreement with Haleon
×
Wellnex Life Extends Supply Agreement with Haleon |
29 June 23 |
Invitation to Investor Webinar on 4 July
×
Invitation to Investor Webinar on 4 July |
29 July 22 |
Appendix 4C and Quarterly Report for June 2022 Quarter
×
Appendix 4C and Quarterly Report for June 2022 Quarter |
29 July 21 |
Investor Presentation
×
Investor Presentation |
29 April 22 |
Appendix 4C and Quarterly Report for March 2022 Quarter
×
Appendix 4C and Quarterly Report for March 2022 Quarter |
28 October 22 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 October 22 |
Appendix 4C and Quarterly Report for September 2022 Quarter
×
Appendix 4C and Quarterly Report for September 2022 Quarter |
28 March 22 |
Change in substantial holding
×
Change in substantial holding |
28 March 22 |
Change in substantial holding
×
Change in substantial holding |
28 March 22 |
Appendix 3Y - George Karafotias
×
Appendix 3Y - George Karafotias |
28 July 23 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
28 February 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
28 February 23 |
Wellnex Life Releases Half Year Report
×
Wellnex Life Releases Half Year Report |
28 February 22 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
28 February 22 |
Wellnex Life Releases Half Year Report
×
Wellnex Life Releases Half Year Report |
28 April 23 |
Appendix 4C and Quarterly Report for March 2023 Quarter
×
Appendix 4C and Quarterly Report for March 2023 Quarter |
26 May 23 |
Application for quotation of securities - WNX
×
Application for quotation of securities - WNX |
26 May 23 |
Proposed issue of securities - WNX
×
Proposed issue of securities - WNX |
26 May 23 |
Proposed issue of securities - WNX
×
Proposed issue of securities - WNX |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.